| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DGCR8 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ITGB5 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | MYO1B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | MBD3L4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | ATP6AP1L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | FOSL2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | CD33 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | SLC38A5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CPT1A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PDZD11 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
